Non‐Biological Complex Drugs/
News
FDA approves first follow-on version of glatiramer acetate
Non‐Biological Complex Drugs/News
|
Posted 05/11/2015
The US Food and Drug Administration (FDA) announced on 16 April 2015 the approval of the first follow-on version of glatiramer acetate injection used to treat patients with relapsing forms of multiple sclerosis (MS).